Now showing items 1-1 of 1

    • A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials. 

      Ingles Garces, AH; Ang, JE; Ameratunga, M; Chénard-Poirier, M; Dolling, D; Diamantis, N; Seeramreddi, S; Sundar, R; de Bono, J; Lopez, J; Banerji, U (2018-11)
      BACKGROUND:The incidence and clinical significance of electrolyte abnormalities (EAs) in phase I clinical trials are unknown. The objective of this study is to evaluate the incidence and severity of EAs, graded according ...